ADARx Pharmaceuticals news
$14.91+12.11%
Close Nov 12, 2026 · split-adjustedArticles · 30 days0English, de-duplicated
Positive0
Neutral0
Negative0
About ADARx Pharmaceuticals
No recent articles focused on ADARx Pharmaceuticals.
Also mentions ADRX
Articles that tag ADRX but are mainly about other companies.
None recently.
Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology